for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover   American Journal of Pharmacological Sciences
  [3 followers]  Follow
  This is an Open Access Journal Open Access journal
   ISSN (Print) 2327-6711 - ISSN (Online) 2327-672X
   Published by Science and Education Publishing Homepage  [72 journals]
  • The Use of Intravenous Immunoglobulins (IVIG) in Immunological Mediated
           Diseases and Possible Mechanisms of Actions

    • Authors: Angel Alberto Justiz Vaillant; Sehlule Vuma, Wayne Mohammed
      Pages: 33 - 37
      Abstract: Intravenous immunoglobulin (IVIG) is a product prepared from fractionation of pools of thousands of plasma donations collected at blood transfusion services. IVIG has been used in the treatment of neurological disorders, primary and secondary immunodeficiency, skin disorders, autoimmune disorders, immunologic abortion, and as anti-cancer and anti-inflammatory therapy. In this paper we listed a number of diseases for which the use of IVIG has been successful and the most mentioned mechanisms of actions of this immunotherapy. IVIG has different modes of actions involving interference with activation of complement components and the cytokine network; effects on regulatory T cells (Tregs) subset; expression of Fc receptors; modulation of idiotype network; and activation, proliferation and effector functions of B and T lymphocytes and of antigen-presenting cells such as dendritic cells and macrophages. We concluded that IVIG has proven to be efficacious in the treatment of immunodeficiency, autoimmunity, infections and inflammatory disorders over the last three decades. To date IVIG has been used to treat more than 80 diseases. Although some of the mechanisms of actions of IVIG are obscure in nature, the fact that many patients improved with it when all other options of treatment were exhausted, make the use of IVIG an important alternative. On the other hand, treatment with IVIG is expensive. We are hopeful that in near future new horizons will be open for the acquisition and use of a cheaper IVIG to treat weak immune system or as immunosuppressive drug in the treatment of autoimmune and inflammatory disorders.
      PubDate: 2015-04-08
      Issue No: Vol. 3, No. 2 (2015)
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015